CAMBRIDGE, Mass. (AP) _ Bluebird Bio Inc. (BLUE) on Wednesday reported a loss of $194.7 million in its third quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of $2.94.
The results topped Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for a loss of $3.07 per share.
The biotechnology company posted revenue of $19.3 million in the period, which did not meet Street forecasts. Nine analysts surveyed by Zacks expected $26 million.
Bluebird shares have dropped 33% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $58.55, a decrease of 29% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BLUE at https://www.zacks.com/ap/BLUE
Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News